JT

Juliet Tammenoms Bakker

Co-Founder, Managing Director at Longitude Capital

Greenwich, Connecticut

VC
Investor

Invests in

Stages:

Series A
Seed

  • Min Investment:

    $100,000.00

  • Max Investment:

    $5,000,000.00

  • Target Investment:

    $1,500,000.00

Education

Lists including Juliet

AP
AO
AS
AN

Based in UK

1884 people

AT
AS
AT
AH

All Series A Investors

14752 people

AM
AT
AS
AR

All Seed Investors

19695 people

Investments

Endogenex

Series C

Total Funding: $100M

Ceribell

Series C

Total Funding: $53M

Eargo

Series E

Total Funding: $220M

Axonics Modulation Technologies

Venture Round

Total Funding: $60M

Alphaeon

Series A

Total Funding: $160M

ALPHAEON Corporation

Series A

Total Funding: $110M

RxSight

Series Unknown

Total Funding: $52M

Venus Concept

Series Unknown

Total Funding: $10M

AqueSys

Series C

Total Funding: $79M

Sadra Medical

Series A

Total Funding: $58M

Work Experience

LC
Longitude Capital

2007

  • Co-Founder, Managing Director

    2007

C│
Ceribell │ Rapid Response EEG

2021

  • Board Member

    2021

S
Sydnexis

2023

  • Board Member

    2023

E
Endogenex

2018

  • Board Member

    2018

NM
Nalu Medical, Inc

2015

  • Board Member

    2015

RI
RxSight, Inc.

2015

  • Board Member

    2015

E
Eargo

2020 - 2021

  • Board Member

    2020 - 2021

AM
Axonics Modulation Technologies, Inc.

2018 - 2020

  • Board Member

    2018 - 2020

FORMER BOARD MEMBER

1997 - 2015

  • Director

    1997 - 2015

    Aquesys, Ablation Frontiers, Aptus Endosystems, Broncus Technologies, Cryovascular Systems, Disc Dynamics, Embolic Protection, Enteric Medical, Facet Solutions, eyeonics, Genyx Medical, Insulet (NASDAQ:PODD), PixelOptics, Precision Dermatology, Sadra Medical and Sanarus Medical.

Pequot Capital

1997 - 2006

  • Managing Director, Co-head of Life Sciences Venture Capital Practice

    1997 - 2006